JP2003519164A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519164A5
JP2003519164A5 JP2001549618A JP2001549618A JP2003519164A5 JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5 JP 2001549618 A JP2001549618 A JP 2001549618A JP 2001549618 A JP2001549618 A JP 2001549618A JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5
Authority
JP
Japan
Prior art keywords
peptide
release
polymer
formulation
dth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001549618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519164A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/000030 external-priority patent/WO2001049249A2/fr
Publication of JP2003519164A publication Critical patent/JP2003519164A/ja
Publication of JP2003519164A5 publication Critical patent/JP2003519164A5/ja
Pending legal-status Critical Current

Links

JP2001549618A 1999-12-31 2001-01-02 ポリマーマトリクスに基づく生理活性化合物徐放調節用医薬製剤 Pending JP2003519164A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17413799P 1999-12-31 1999-12-31
US60/174,137 1999-12-31
PCT/US2001/000030 WO2001049249A2 (fr) 1999-12-31 2001-01-02 Formulation pharmaceutique destinee a reguler la liberation dans le temps de composes biologiquement actifs a base d'une matrice polymere

Publications (2)

Publication Number Publication Date
JP2003519164A JP2003519164A (ja) 2003-06-17
JP2003519164A5 true JP2003519164A5 (fr) 2011-04-28

Family

ID=22634986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001549618A Pending JP2003519164A (ja) 1999-12-31 2001-01-02 ポリマーマトリクスに基づく生理活性化合物徐放調節用医薬製剤

Country Status (5)

Country Link
EP (1) EP1263453A4 (fr)
JP (1) JP2003519164A (fr)
AU (1) AU784226B2 (fr)
CA (1) CA2396037A1 (fr)
WO (1) WO2001049249A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251864A4 (fr) * 1999-12-31 2006-02-22 Univ Rutgers Formulation pharmaceutique composee d'un melange polymere et d'un compose actif pour une liberation regulee dans le temps
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
ES2383525T3 (es) 2003-11-05 2012-06-21 Sarcode Bioscience Inc. Moduladores de la adhesión celular
CA2609053C (fr) 2005-05-17 2017-04-25 Sarcode Corporation Compositions et procedes pour le traitement des troubles oculaires
US8315700B2 (en) 2006-02-08 2012-11-20 Tyrx, Inc. Preventing biofilm formation on implantable medical devices
EP2114298B1 (fr) 2006-02-08 2022-10-19 Medtronic, Inc. Prothèses de type treillis temporairement raidies
US9265865B2 (en) 2006-06-30 2016-02-23 Boston Scientific Scimed, Inc. Stent having time-release indicator
JP2010508915A (ja) 2006-11-06 2010-03-25 タイレックス・ファーマ・インコーポレイテッド 埋込型医療機器のためのメッシュパウチ
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
CA2682190C (fr) 2007-03-29 2015-01-27 Tyrx Pharma, Inc. Enveloppes polymeres biodegradables pour implants mammaires
WO2008137807A1 (fr) 2007-05-02 2008-11-13 Tyrx Pharma, Inc. Polymères de dihydroxybenzoate et leurs utilisations
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
EP3797775A1 (fr) 2007-10-19 2021-03-31 Novartis AG Compositions et procédés pour le traitement de la rétinopathie diabétique
WO2009139817A2 (fr) 2008-04-15 2009-11-19 Sarcode Corporation Produit pharmaceutique cristallin et ses procédés de préparation et d'utilisation
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8652525B2 (en) 2008-07-10 2014-02-18 Tyrx, Inc. NSAID delivery from polyarylates
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
JP5671463B2 (ja) 2008-09-22 2015-02-18 タイレックス・インコーポレイテッドTyrx Inc. アミノフェノールエステルからの直鎖ポリエステルアミド
US9839628B2 (en) 2009-06-01 2017-12-12 Tyrx, Inc. Compositions and methods for preventing sternal wound infections
EP2437724B1 (fr) * 2009-06-01 2015-09-30 Tyrx, Inc. Compositions et méthodes pour prévenir les infections de blessures sternales
US9080015B2 (en) * 2009-07-31 2015-07-14 Rutgers, The State University Of New Jersey Biocompatible polymers for medical devices
US8409279B2 (en) 2009-10-01 2013-04-02 Lipose Corporation Breast implant implantation method and apparatus
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
AU2011293344B2 (en) 2010-08-25 2015-07-30 Medtronic, Inc. Novel medical device coatings
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012064963A1 (fr) 2010-11-12 2012-05-18 Tyrx, Inc. Dispositifs d'ancrage comprenant un principe pharmaceutique actif
US9381281B2 (en) 2011-07-20 2016-07-05 Tyrx, Inc. Drug eluting mesh to prevent infection of indwelling transdermal devices
MX2015001098A (es) 2012-07-25 2015-09-25 Sarcode Bioscience Inc Inhibidor del antigeno-1 asociado a la funcion del linfocito (lfa-1) y polimorfo del mismo.
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
WO2014137454A1 (fr) 2013-03-07 2014-09-12 Tyrx, Inc. Procédés et compositions permettant d'inhiber l'assemblage de cellules microbiennes se liant de façon irréversible à la surface de dispositifs médicaux
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EP3054969B1 (fr) 2013-10-10 2021-03-10 Bausch Health Ireland Limited Agonistes de guanylate cyclase utiles pour le traitement de troubles induits par les opioïdes
WO2015069305A1 (fr) 2013-11-08 2015-05-14 Tyrx, Inc. Compositions antimicrobiennes et procédés de prévention d'infection dans des sites d'incision chirurgicale
WO2016020308A1 (fr) * 2014-08-04 2016-02-11 Janssen Sciences Ireland Uc Forme posologique solide comprimée
CA3009814A1 (fr) 2016-01-11 2017-07-20 Synergy Pharmaceuticals, Inc. Formulations et methodes pour traiter la rectocolite hemorragique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587507A (en) * 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5658995A (en) * 1995-11-27 1997-08-19 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
US6120491A (en) * 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
WO1998036013A1 (fr) * 1997-02-18 1998-08-20 Rutgers, The State University Monomeres derives d'acides hydroxyliques et polymeres prepares a partir de ceux-ci
DE19719817A1 (de) * 1997-05-13 1998-11-19 Hoechst Ag Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
ZA9811377B (en) * 1997-12-12 1999-08-27 Expression Genetics Inc Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid[ for the delivery of a bioactive agent via tissue and cellular uptake.
JP4312384B2 (ja) * 1998-04-13 2009-08-12 ラットガーズ ザ ステイト ユニヴァーシティ コポリマーライブラリーの構築
AU2373200A (en) * 1999-02-05 2000-08-25 Alien Technology Corporation Apparatuses and methods for forming assemblies

Similar Documents

Publication Publication Date Title
JP2003519164A5 (fr)
Bose et al. Biodegradable polymers for modern vaccine development
US4942035A (en) Continuous release formulations
TWI250028B (en) Biodegradable ph/thermosensitive hydrogel for sustained delivery of biologically active agents
Gombotz et al. Protein release from alginate matrices
ES2432556T3 (es) Métodos para fabricar dispositivos de suministro y sus dispositivos
US5529777A (en) Hydrogel microencapsulated vaccines
US4863735A (en) Biodegradable polymeric drug delivery system with adjuvant activity
US4882168A (en) Polyesters containing alkylene oxide blocks as drug delivery systems
Kissel et al. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly (lactide-co-glycolide) A blocks and hydrophilic poly (ethylene oxide) B blocks
CA1288344C (fr) Systeme de dispensation de medicament
JP2007308500A (ja) Gm−csfの放出の延長
CA2203857A1 (fr) Microparticules pour l'expression d'acide nucleique
WO2002036169A3 (fr) Methodes et compositions pour ameliorer l'administration de molecules bioactives
PT863933E (pt) Novos hidrogeis a base de copolimeros de bloco com res sequencias sua preparacao e sua aplicacao
NZ204643A (en) Controlled release device containing polymer and acid anhydride
KR20090086478A (ko) 약물 전달을 위한 생분해가능 블록 공중합성 조성물
EP0258780A2 (fr) Polyesters contenant des séquences d'oxyde d'alkylène et leur utilisation comme systèmes de libération de médicaments
CN101331173A (zh) 生物相容性嵌段共聚物、其用途和制造方法
CA2424936A1 (fr) Composition de vaccin renfermant une substance immunologiquement active logee dans des microparticules faites d'un amidon au poids moleculaire reduit
CA2167081A1 (fr) Vaccins microencapsules a base d'hydrogel
WO1995002416A9 (fr) Vaccins microencapsules sur une base d'hydrogel
Ghahremankhani et al. PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery
AL et al. Biodegradable polymers: Which, when and why?
JP2013536177A (ja) 2−ヒドロキシアルキル酸から調製されたポリマーを含む組成物